RTI International - turning knowledge into practice

Site Map   Contact RTI
  • Home
  • About RTI
  • Expertise
  • RTI Newsroom
  • Published Research
  • Careers
  • Working with RTI
  • Drug Discovery & Development
  • Drug Discovery
  • Drug Development Services
  • Clinical Research
Drug Discovery & Development Page Tools AddThis

Senior Researcher-Clinical Studies Specialist

  • lhammrti.org
  • 919-541-6789
  • Research Triangle Park, NC
Lynne Hamm
 download image

Lynne R. Hamm

Expertise

Clinical Operations
Clinical Study Design
Clinical Study Recruitment

Biography

Lynne Hamm is senior director of clinical and medical services at RTI Health Solutions. She has extensive experience in the pharmaceutical industry designing, implementing, and managing Phase 2-4 clinical studies. Ms. Hamm has developed specifications for interactive voice response systems (IVRS) to facilitate the electronic capture of subject diary data and has experience using IVRS in large international studies. Ms. Hamm has been involved with multiple clinical studies in the United States, Canada, Mexico, and Europe. She has experience with national call centers and script development to assist in subject referral to study sites in response to nationwide study recruitment advertising. While working in the pharmaceutical industry, Ms. Hamm has been involved in protocol design, study report writing, preparations for FDA Advisory Committees, and NDA submissions.

Education

BSN, Family Nurse Practitioner, Purdue University-Calumet; AAS, Purdue University-North Central.


Selected Publications

Andrews, E.B., Eaton, S.C., Hollis, K.A., Hopkins, J.S., Ameen, V.Z., Hamm, L.R., Mangel, A.W., Tennis, P., & Cook, S.F. (2005). Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Alimentary Pharmacology and Therapeutics, 2005 (22):935-942.
Berman, S.M., Chang, L., Suyenobu, B., Derbyshire, S.W., Stains, J., Fitzgerald, L., Mandelkern, M., Hamm, L., Vogt, B., Naliboff, B.D., & Mayer, E.A. (2002 Oct). Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron. Gastroenterology, 123 (4):969-977.
Mayer, E.A., Berman, S., Derbyshire, S.W., Suyenobu, B., Chang, L., Fitzgerald, L., Mandelkern, M., Hamm, L., Vogt, B., & Naliboff, B.D. (2002 Jul). The effect of the 5-HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients. Alimentary Pharmacology and Therapeutics, 16 (7):1357-1366.
Hamm, L.R., Sorrells, S.C., Harding, J.P., Northcutt, A.R., Heath, A.T., Kapke, G.F., Hunt, C.M., & Mangel, A.W. (1999 May). Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria. American Journal of Gastroenterology, 94 (5):1279-1282.
Harding, J.P., Hamm, L.R., Ehsanullah, R.S., Heath, A.T., Sorrells, S.C., Haw, J., Dukes, G.E., Wolfe, S.G., Mangel, A.W., & Northcutt, A.R. (1997 Dec). Use of a novel electronic data collection system in multicenter studies of irritable bowel syndrome. Alimentary Pharmacology and Therapeutics, 11 (6):1073-1076.

View all publications by Lynne R. Hamm…



Site Map | Contact Us | Subscribe | Terms & Conditions | Privacy Statement | Accessibility | Standards Version
©2009 RTI International. RTI International is a trade name of Research Triangle Institute.